Cognitive & Neuropeptide Research
Nootropic and neuropeptide compounds for cognitive and neurological pathway research, including Semax, Selank, and Dihexa.
Cognitive and neuropeptide compounds are studied for their influence on BDNF signalling, neurotransmitter regulation, and neuroplasticity. Semax is an ACTH(4–10) analogue developed at the Institute of Molecular Genetics in Moscow, investigated as a BDNF and VEGF modulator. Selank is a tuftsin analogue studied for anxiolytic and GABAergic effects. Dihexa is among the most active pro-cognitive compounds in pre-clinical models. Orexin A and B regulate hypothalamic arousal and appetite circuits.

DSIP (Delta Sleep-Inducing Peptide)
Mol. Wt.
848.81 g/mol
Purity
≥98%
CAS No.
62568-57-4

Cerebrolysin
Mol. Wt.
Variable; peptide fractions predominantly <10 kDa
Purity
≥98%
CAS No.
N/A (complex peptide mixture)
For in-vitro research use only. Not for human or veterinary use.











